Replacement of Lamivudine by Telbivudine to Improve Renal Function

Status Completed

Clinical Trial Summary

Nephrotoxicity is one of the adverse effects of lamivudine and dosage of lamivudine has to be reduced if patients' renal function is insufficiency. Telbivudine may improve glomerular filtration rate. This study is to see whether renal function is improved when Lamivudine is replaced by telbivudine in liver transplantation patients.

Clinical Trial Description

Liver transplantation is the only effective treatment for the patients with liver failure. Hepatitis B-related liver cirrhosis is the major indication to have liver transplantation in Taiwan. After liver transplantation, prophylaxis of hepatitis B recurrence will be performed by anti-hepatitis B immunoglobulin and anti-viral agents. Currently, lamivudine is the drug the investigators choose to prevent HBV recurrence for many years because it is safe for long-term use. However, nephrotoxicity is one of the adverse effects of lamivudine and dosage of lamivudine has to be reduced if patients' renal function is insufficiency. Recently, the studies on chronic hepatitis B patients showed improvement of glomerular filtration rate for those receiving telbivudine treatment. In this study, the investigators will include our post-transplant HBV patients who have stable liver function, receive lamivudine for prophylaxis of recurrent hepatitis B, and have renal dysfunction in stage II-IV. The patients will be randomized to receive telbivudine or lamivudine continuously at 1:1 ratio. Renal function will be examined at 6 months interval to determine whether renal function is improved. The achievement will determine whether telbivudine is better than lamivudine for the HBV patients with renal dysfunction. ;

Study Design

Related Conditions & MeSH terms

Disorder Related to Transplantation
Injury Due to Exposure to External Cause
Virus Diseases

Clinical Trial Details

NCT number	NCT02447705
Study type	Interventional
Source	Chang Gung Memorial Hospital
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	June 2013
Completion date	January 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04074928` - Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects	Phase 3
Completed	`NCT03321968` - Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults	Phase 3
Completed	`NCT04644484` - A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety	Phase 3
Completed	`NCT00984945` - Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults	Phase 1
Completed	`NCT00734175` - Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine	Phase 1
Completed	`NCT00516035` - Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults	Phase 1
Active, not recruiting	`NCT05284097` - Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study	Phase 2
Completed	`NCT03739112` - Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly	Phase 3
Recruiting	`NCT06113757` - Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease	N/A
Completed	`NCT01991587` - Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults	Phase 1/Phase 2
Completed	`NCT03294135` - The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine	Phase 4
Active, not recruiting	`NCT02545517` - A Clinical Study to Evaluate Immune Responses to Rabies Vaccine in Adults Who Received Different Primary Rabies Vaccination Regimens	Phase 3
Active, not recruiting	`NCT05619770` - Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects	Phase 1
Not yet recruiting	`NCT01289301` - Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant	Phase 4
Active, not recruiting	`NCT01055990` - Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients	Phase 2
Completed	`NCT01842997` - Safety of H1N1 Influenza Vaccination in Pregnant Women	Phase 4
Completed	`NCT00980447` - Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults	Phase 2
Completed	`NCT00380237` - Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)	Phase 1
Completed	`NCT00219453` - Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination	Phase 1
Completed	`NCT02548078` - A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children	Phase 2